All these molecular events occurred during BC cell stemness transformation inducing CD44v generation, which is the canonical biomarker of CSCs and a valuable indicator of poor prognosis.[34, 41] In summary, these data implied that CDK5 surely control TNBC cell stemness transformation. This evidence concerns the gene CDK5 and breast cancer.